[
  {
    "num_questions": 35,
    "randomize": false,
    "questions": [
      {
        "type": ["multiple choice"],
        "text": [
          "Regions of the brain affected by prolonged use of addictive substances are involved in which processes (among others)?"
        ],
        "point_value": 1,
        "answers": [
          "Motivation and reward",
          "Reward and creativity",
          "Creativity and high-level problem solving",
          "High-level problem solving and motivation"
        ],
        "correct_answers": ["Motivation and reward"],
        "randomize": [true]
      },
      {
        "type": ["multiple choice"],
        "text": [
          "Which agent is combined with naloxone to help treat opioid addiction?"
        ],
        "point_value": 1,
        "answers": ["Methadone", "Buprenorphine", "Heroin", "OxyContin"],
        "correct_answers": ["Buprenorphine"],
        "randomize": [true]
      },
      {
        "type": ["multiple choice"],
        "text": [
          "_____________ is a natural opioid/are natural opioids produced in the body."
        ],
        "point_value": 1,
        "answers": ["Dopamine", "Endorphins", "Glutamate", "Acetylcholine"],
        "correct_answers": ["Endorphins"],
        "randomize": [true]
      },
      {
        "type": ["multiple choice"],
        "text": [
          "______________ is the neurotransmitter associated with feelings of pleasure."
        ],
        "point_value": 1,
        "answers": ["Dopamine", "Endorphins", "Glutamate", "Acetylcholine"],
        "correct_answers": ["Dopamine"],
        "randomize": [true]
      },
      {
        "type": ["multiple choice"],
        "text": ["Tolerance is defined as:"],
        "point_value": 1,
        "answers": [
          "A variety of unpleasant symptoms occurring after the use of opioids is reduced or stopped",
          "A condition in which higher doses of opioids are required to produce the same effects as during initial use",
          "The recurrence of opioid use after a period of abstinence",
          "An adaptive physiological state occurring with regular opioid use that results in a withdrawal syndrome if opioid use is stopped"
        ],
        "correct_answers": [
          "A condition in which higher doses of opioids are required to produce the same effects as during initial use"
        ],
        "randomize": [true]
      },
      {
        "type": ["multiple choice"],
        "text": [
          "Suboxone sublingual tablets contain buprenorphine, a partial agonist at the mu-opioid receptor, and naloxone, an antagonist at the mu-opioid receptor."
        ],
        "point_value": 1,
        "answers": ["True", "False"],
        "correct_answers": ["True"],
        "randomize": [false]
      },
      {
        "type": ["multiple choice"],
        "text": [
          "Which of the following screening tools takes less than a minute to administer and is scored instantaneously?"
        ],
        "point_value": 1,
        "answers": ["BAM", "AUDIT", "PACS", "CAGE"],
        "correct_answers": ["CAGE"],
        "randomize": [true]
      },
      {
        "type": ["multiple choice"],
        "text": [
          "Which of the following agents is administered on a once-monthly schedule?"
        ],
        "point_value": 1,
        "answers": [
          "Disulfiram",
          "Acamprosate",
          "Oral naltrexone",
          "Extended release injectable naltrexone"
        ],
        "correct_answers": ["Extended release injectable naltrexone"],
        "randomize": [true]
      },
      {
        "type": ["multiple choice"],
        "text": ["Methadone is a _______________."],
        "point_value": 1,
        "answers": [
          "partial agonist",
          "full agonist",
          "antagonist",
          "none of these is correct"
        ],
        "correct_answers": ["full agonist"],
        "randomize": [false]
      },
      {
        "type": ["multiple choice"],
        "text": ["Buprenorphine is a(n) _______________."],
        "point_value": 1,
        "answers": [
          "partial agonist",
          "full agonist",
          "antagonist",
          "none of these is correct"
        ],
        "correct_answers": ["partial agonist"],
        "randomize": [false]
      },
      {
        "type": ["multiple choice"],
        "text": ["Methadone is a _____________________ narcotic."],
        "point_value": 1,
        "answers": ["Schedule I", "Schedule II", "Schedule III", "Schedule IV"],
        "correct_answers": ["Schedule II"],
        "randomize": [false]
      },
      {
        "type": ["multiple choice"],
        "text": ["What is the route of administration for methadone?"],
        "point_value": 1,
        "answers": ["injection", "sublingual", "intravenous", "oral liquid"],
        "correct_answers": ["oral liquid"],
        "randomize": [true]
      },
      {
        "type": ["multiple choice"],
        "text": ["Buprenorphine is a ____________ narcotic."],
        "point_value": 1,
        "answers": ["Schedule I", "Schedule II", "Schedule III", "Schedule IV"],
        "correct_answers": ["Schedule III"],
        "randomize": [false]
      },
      {
        "type": ["multiple choice"],
        "text": ["Which of the following is a behavioral treatment goal?"],
        "point_value": 1,
        "answers": [
          "Improving problem-solving skills",
          "Providing incentives for abstinence",
          "Facilitating better interpersonal relationships",
          "All of the above"
        ],
        "correct_answers": ["All of the above"],
        "randomize": [false]
      },
      {
        "type": ["multiple choice"],
        "text": [
          "Oral naltrexone is indicated for the treatment of opioid dependence."
        ],
        "point_value": 1,
        "answers": ["True", "False"],
        "correct_answers": ["False"],
        "randomize": [false]
      },
      {
        "type": ["multiple select"],
        "text": [
          "Which of the following are indications for VIVITROL? (Select all that apply.)"
        ],
        "point_value": 1,
        "answers": [
          "The treatment of alcohol tolerance as part of a comprehensive management program that includes psychosocial support",
          "The treatment of alcohol dependence in patients who are able to abstain from alcohol in an outpatient setting prior to initiation of treatment with VIVITROL; Patients should not be actively drinking at the time of initial VIVITROL administration",
          "The prevention of relapse to opioid dependence following opioid detoxification",
          "VIVITROL should be part of a comprehensive management program that includes psychosocial support"
        ],
        "correct_answers": [
          "The treatment of alcohol dependence in patients who are able to abstain from alcohol in an outpatient setting prior to initiation of treatment with VIVITROL; Patients should not be actively drinking at the time of initial VIVITROL administration",
          "The prevention of relapse to opioid dependence following opioid detoxification",
          "VIVITROL should be part of a comprehensive management program that includes psychosocial support"
        ],
        "randomize": [true]
      },
      {
        "type": ["multiple choice"],
        "text": ["The recommended dose of VIVITROL is__________________."],
        "point_value": 1,
        "answers": ["190 mg", "250 mg", "380 mg", "400 mg"],
        "correct_answers": ["380 mg"],
        "randomize": [true]
      },
      {
        "type": ["multiple choice"],
        "text": [
          "Prior to preparation, approximately how much time should be allowed for the contents of VIVITROL to reach room temperature?"
        ],
        "point_value": 1,
        "answers": ["15 minutes", "30 minutes", "45 minutes", "60 minutes"],
        "correct_answers": ["45 minutes"],
        "randomize": [false]
      },
      {
        "type": ["multiple choice"],
        "text": [
          "The adverse events seen most frequently in association with VIVITROL therapy in opioid- dependent patients (i.e., those occurring in â‰¥2% of patients treated with VIVITROL and at least twice as frequently with VIVITROL than placebo) were all of the following except for:"
        ],
        "point_value": 1,
        "answers": [
          "Hepatic enzyme abnormalities",
          "Injection site pain",
          "Nasopharyngitis",
          "Insomnia",
          "Toothache",
          "Headache"
        ],
        "correct_answers": ["Headache"],
        "randomize": [true]
      },
      {
        "type": ["multiple choice"],
        "text": [
          "True or False, VIVITROL administered by a healthcare provider as an intramuscular (IM) gluteal injection, should alternate buttocks for each subsequent injection, using the carton components provided."
        ],
        "point_value": 1,
        "answers": ["True", "False"],
        "correct_answers": ["True"],
        "randomize": [false]
      },
      {
        "type": ["multiple choice"],
        "text": [
          "Which of the following is one of the warnings and precautions for VIVITROL is for:"
        ],
        "point_value": 1,
        "answers": [
          "renal failure",
          "seizures",
          "injection site reactions",
          "insomnia"
        ],
        "correct_answers": ["injection site reactions"],
        "randomize": [true]
      },
      {
        "type": ["multiple choice"],
        "text": [
          "Approximately how many alcohol dependent and opioid dependent patients were treated with VIVITROL in the controlled and uncontrolled premarketing VIVITROL studies?"
        ],
        "point_value": 1,
        "answers": ["550", "900", "1100", "2500"],
        "correct_answers": ["1100"],
        "randomize": [true]
      },
      {
        "type": ["multiple choice"],
        "text": [
          "In the controlled clinical trial, which adverse event led to more dropouts of alcohol dependent patients in the VIVITROL 380 mg group than in the placebo treated group?"
        ],
        "point_value": 1,
        "answers": [
          "injection site reactions",
          "syncope",
          "anorexia",
          "nausea"
        ],
        "correct_answers": ["injection site reactions"],
        "randomize": [true]
      },
      {
        "type": ["multiple choice"],
        "text": [
          "What percentage of opioid dependent patients treated with VIVITROL in the controlled trial discontinued treatment due to an adverse event?"
        ],
        "point_value": 1,
        "answers": ["0%", "2%", "9%", "15%"],
        "correct_answers": ["2%"],
        "randomize": [true]
      },
      {
        "type": ["multiple choice"],
        "text": ["VIVITROL is an opioid:"],
        "point_value": 1,
        "answers": ["agonist", "partial agonist", "antagonist"],
        "correct_answers": ["antagonist"],
        "randomize": [true]
      },
      {
        "type": ["multiple choice"],
        "text": ["Which of the following is true about VIVITROL?"],
        "point_value": 1,
        "answers": [
          "Plasma concentrations of VIVITROL are highest 14 days after administration",
          "VIVITROL plasma concentration rapidly decline after 3 days",
          "VIVITROL is a rapid-release formulation and is administered weekly",
          "Plasma concentrations of VIVITROL peak after 2 hours and again after 2 to 3 days"
        ],
        "correct_answers": [
          "Plasma concentrations of VIVITROL peak after 2 hours and again after 2 to 3 days"
        ],
        "randomize": [true]
      },
      {
        "type": ["multiple choice"],
        "text": [
          "The elimination half-life of naltrexone following VIVITROL administration is _____ days and is dependent on the erosion of the polymer."
        ],
        "point_value": 1,
        "answers": ["1-3", "4-8", "5-10", "15-18"],
        "correct_answers": ["5-10"],
        "randomize": [true]
      },
      {
        "type": ["multiple choice"],
        "text": [
          "VIVITROL is metabolized by P450 enzymes and therefore has a high potential for interaction with other drugs"
        ],
        "point_value": 1,
        "answers": ["True", "False"],
        "correct_answers": ["False"],
        "randomize": [false]
      },
      {
        "type": ["multiple choice"],
        "text": [
          "All of the following were treatment groups in the alcohol dependence efficacy trial except?"
        ],
        "point_value": 1,
        "answers": [
          "190 mg VIVITROL",
          "380 mg VIVITROL",
          "500 mg VIVITROL",
          "placebo"
        ],
        "correct_answers": ["500 mg VIVITROL"],
        "randomize": [true]
      },
      {
        "type": ["multiple choice"],
        "text": [
          "How many patients were included in the 24-week efficacy trial of VIVITROL for opioid dependence?"
        ],
        "point_value": 1,
        "answers": ["250", "510", "624", "1100"],
        "correct_answers": ["250"],
        "randomize": [true]
      },
      {
        "type": ["multiple choice"],
        "text": [
          "Complete abstinence, defined as opioid-free at all weekly visits, was sustained by 23% of the subjects in the placebo group compared with ____ of the subjects in the VIVITROL group from Week 5 to Week 24."
        ],
        "point_value": 1,
        "answers": ["5%", "25%", "36%", "52%"],
        "correct_answers": ["36%"],
        "randomize": [true]
      },
      {
        "type": ["multiple choice"],
        "text": [
          "Subjects treated with VIVITROL 380 mg demonstrated a greater reduction in days of heavy drinking than those treated with placebo"
        ],
        "point_value": 1,
        "answers": ["True", "False"],
        "correct_answers": ["True"],
        "randomize": [false]
      },
      {
        "type": ["multiple choice"],
        "text": [
          "Heavy drinking was defined as self-report of __ or more standard drinks consumed on a given day for male patients and __ or more drinks for female patients"
        ],
        "point_value": 1,
        "answers": ["5, 4", "6, 5", "4, 5", "7, 5"],
        "correct_answers": ["5, 4"],
        "randomize": [true]
      },
      {
        "type": ["multiple choice"],
        "text": [
          "In the study by Krupitsky et al., the median percentage of opioid-free weeks (from weeks 5 through 24) for patients in the VIVITROL plus psychosocial support group was significantly higher than that of the placebo plus psychosocial group."
        ],
        "point_value": 1,
        "answers": ["True", "False"],
        "correct_answers": ["True"],
        "randomize": [false]
      },
      {
        "type": ["multiple choice"],
        "text": [
          "Among opioid-dependent patients who received VIVITROL and placebo, the rate of discontinuation due to adverse events was 2%."
        ],
        "point_value": 1,
        "answers": ["True", "False"],
        "correct_answers": ["True"],
        "randomize": [false]
      }
    ]
  }
]
